Recruiting NA Gastrointestinal Malignancy

New treatment option for Gastrointestinal Malignancy

Official title The Erector Spinae Plane Block For Gastrointestinal Malignancy Pain Treatment (EGIPT)

ClinicalTrials.gov ID: NCT07211386

What this study is testing

What it's testing
This study will target patients with gastrointestinal (GI) malignancy who present to any of 4 Penn Medicine emergency departments (EDs) with intractable abdominal pain. We will offer eligible patients an erector spinae plane block (ESPB), a regional anesthesia technique which is already offered to such patients in the ED at the University of Pennsylvania Healthy System (UPHS), for their intractable abdominal pain.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients age \> 18 years old with GI malignancy presenting to a Penn Medicine ED with intractable abdominal pain.
  • Same-day or recent CT scan of the abdomen / pelvis which demonstrates that the patient's abdominal pain can be reasonably attributed to a malignant...

You likely can't join if

  • Allergy to ropivacaine or history of local anesthetic systemic toxicity.
  • Pregnancy
  • Incarcerated
  • Patients being admitted for serial abdominal examinations to determine their surgical course.
  • Altered mental status or inability for patient to consent for the procedure
  • Hemodynamic instability
See the full eligibility criteria
Who can join
  • Patients age \> 18 years old with GI malignancy presenting to a Penn Medicine ED with intractable abdominal pain.
  • Same-day or recent CT scan of the abdomen / pelvis which demonstrates that the patient's abdominal pain can be reasonably attributed to a malignant source.
What rules you out
  • Allergy to ropivacaine or history of local anesthetic systemic toxicity.
  • Pregnancy
  • Incarcerated
  • Patients being admitted for serial abdominal examinations to determine their surgical course.
  • Altered mental status or inability for patient to consent for the procedure
  • Hemodynamic instability
  • Previously enrolled in the study

The study team makes the final eligibility decision.

Where it's taking place

  • Philadelphia, Pennsylvania, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.